neck squamous cell carcinoma trang 2 tải miễn phí từ TAILIEUCHUNG

"neck squamous cell carcinoma" trang 2 - tải miễn phí từ Tailieuchung

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ ETS-1 signaling pathway

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ ETS-1 signaling pathway

12 88 0

Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma

Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma

13 31 1

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck

9 40 1

A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients

A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients

8 49 1

Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

9 54 2

Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: A pilot study

Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: A pilot study

8 65 1

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: A nationwide retrospective cohort study (KCSG HN13–01)

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: A nationwide retrospective cohort study (KCSG HN13–01)

9 35 1

Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality

Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality

8 67 1

Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models

Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models

9 31 1

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma

15 34 1

Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients

Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients

11 20 1

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

9 32 1

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

13 48 1

Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma

Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma

11 23 1

Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: A study of the SEER database

Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: A study of the SEER database

8 49 3

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex

24 39 3

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma

19 8 1

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial

10 9 1

Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: A retrospective cohort study

Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: A retrospective cohort study

10 9 1

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma

9 30 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.